Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Ways To Identify Overspending Trends helps you recognize patterns over time, enabling proactive adjustments before they derail goals.
13,991 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A harsh Rockies winter weighed on Vail Resorts’ results, pushing the stock lower even as the Epic Pass program gains ...
A longtime investor reevaluates the urge to claim Social Security at 62, choosing to wait for bigger monthly checks a...
A two-year income lookback in Medicare pricing can surprise retirees after asset sales. This report explains how the ...
Dogecoin broke through a multi-session resistance with a heavy volume burst, prompting traders to eye the next hurdle...
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
As Zillow prepares for 2026 earnings season, investors crave clarity on growth, margins, and how the housing cycle co...
Is Bitcoin really the better store value: bitcoin option, or do gold-backed stablecoins offer a compelling alternativ...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...